Fresh From the Bench: Latest Federal Circuit Court Case
Contributed by Schwabe Williamson & Wyatt. Originally published on Patexia; republished here as part of the LexDana archive.
CASE OF THE WEEK
Hologic, Inc. v. Minerva Surgical, Inc., Appeal Nos. 2019-2054, -2081 (Fed. Cir. Aug. 11, 2022)
Our Case of the Week follows the Hologic saga as it returns to the Federal Circuit on remand from the Supreme Court’s decision vacating the prior Federal Circuit opinion in 2021. We covered that decision here. The case concerns the doctrine of assignor estoppel. In this decision on remand, the Federal Circuit concluded that assignor estoppel applied.
The dispute traces back to the early 1990s, when an inventor, Csaba Truckai, co-founded a company called NovaCept and developed an endometrial ablation devices. Mr. Truckai and his co-inventors filed a patent application in 1998. He assigned his rights to NovaCept at that time. NovaCept was acquired by Cytyc Corporation in 2004, and assigned all of its patent rights to Cytyc at the time. As part of the agreement, it warranted the validity of the patents and further warranted it had “no present knowledge from which it could reasonably conclude” that the assigned intellectual property rights were invalid. Cytyc was acquired by Hologic in 2007, and is the current assignee of that patents at issue.
Read more.
By Nika Aldrich
Edited by Scott D. Eads
More insights
Federal Circuit Affirms Invalidation of Patent for Lack of Enablement of Claims Directed to a Method of Treating a Patient with a Unit Dosage in Wyeth Llc v Astrazeneca Pharmaceuticals Lp
Written by : Eric Furman, Ph.D. and Ashley C. Morales Key Takeaway: Federal Circuit invalidates patent claims directed to a method for treating non-small cell lung cancer through administration of “a unit dosage” of an irreversible epidermal…
When About Becomes Indefinite Federal Circuit Provides Guidance for Life Science Patent Applications Regarding Limits of Approximation in Enviro Tech v Safe Foods
Written by : Jason J. Jardine and Kenneth O. Aruda, Ph.D. Key Takeaway: The term “about” remains useful in biotech and pharmaceutical claims, but only if the patent provides objective guidance about what the term means. Absent that guidance,…
When Any Patent Means No Patent Federal Circuit Reverses Non Specific Verdict
Written by : Brian C. Barnes and Sophia F. Zahn OLLNOVA TECHNOLOGIES LTD. v. ECOBEE TECHNOLOGIES ULC [OPINION] Before Chen , Cunningham, and Stark. Appeal from the United States District Court for the Eastern District of Texas. Summary : A verdict form…